Evidence of recombination between 3' and 5' LTRs in macaques inoculated with SIV DNA

Stephen J Kent1, C Jane Dale, Scott Preiss

  • 1Department of Microbiology and Immunology, University of Melbourne, Parkville, Vic, 3010, Australia. skent@unimelb.edu.au

Insights

Researchers discovered that macaques inoculated with simian immunodeficiency virus (SIV) DNA could repair deletions in the viral genome. This in vivo homologous recombination occurred early, suggesting a novel mechanism for viral sequence evolution.

Area of Science:

  • Virology
  • Molecular Biology
  • Primate Models

Background:

  • Proviral simian immunodeficiency virus (SIV) DNA inoculation is a standard method for establishing SIV infections in macaques.
  • Understanding viral genome dynamics during infection is crucial for developing effective interventions.

Purpose of the Study:

  • To investigate the in vivo repair mechanisms of engineered deletions in SIV DNA following inoculation in macaques.
  • To determine if homologous recombination occurs and identify potential mechanisms.

Main Methods:

  • Inoculation of macaques with SIV DNA containing specific deletions in the 3' nef/LTR overlap region.
  • Isolation and sequence analysis of SIV DNA from inoculated animals over time.
  • Comparison of sequences from animals inoculated with single versus dual LTR deletions.

Main Results:

  • Macaques inoculated with SIV DNA having a single deletion in the 3' nef/LTR overlap region showed evidence of deletion repair with wild-type sequences.
  • Animals receiving SIV DNA with identical deletions in both 5' and 3' LTRs did not exhibit deletion repair.
  • Sequence analysis indicated early recombination events, likely through homologous recombination with the 5' LTR.

Conclusions:

  • This study provides the first demonstration of homologous recombination in vivo after administration of a single SIV strain.
  • Engineered deletions in SIV DNA can be repaired by homologous recombination in macaques, influencing viral sequence evolution.
  • The findings highlight the plasticity of the SIV genome and potential implications for vaccine and antiviral strategies.